Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.324,08
-0,89%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Passage Bio Inc (PASG) Passage Bio Inc (PASG) Notizie

Passage Bio Inc

PASG
1,31
-0,03 (-2,24%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202413:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
05/3/202413:00GLOBEPassage Bio Seeks Pennsylvania College Student Candidates..
04/3/202423:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
04/3/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202413:02EDGAR2Form 8-K - Current report
04/3/202413:00GLOBEPassage Bio Reports Fourth Quarter and Full-Year 2023..
29/2/202422:06EDGAR2Form 8-K - Current report
27/2/202413:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:05EDGAR2Form 8-K - Current report
03/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:15EDGAR2Form 8-K - Current report
20/12/202313:05EDGAR2Form 8-K - Current report
20/12/202313:00GLOBEPassage Bio Announces Promising Initial Data From Phase 1/2..
17/11/202322:30GLOBEPassage Bio Announces Inducement Grant Under Nasdaq Listing..
13/11/202313:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:00EDGAR2Form 8-K - Current report
13/11/202313:00GLOBEPassage Bio Reports Third Quarter 2023 Financial Results and..
30/10/202312:00GLOBEPassage Bio to Present at Guggenheim’s 5th Annual..
20/10/202322:30GLOBEPassage Bio Announces Inducement Grants Under Nasdaq Listing..
25/9/202313:00GLOBEPassage Bio to Present at Chardan’s 7th Annual Genetic..
01/9/202322:10EDGAR2Form 8-K - Current report
07/8/202313:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202313:15GLOBEPassage Bio Reports Second Quarter 2023 Financial Results..
07/8/202313:15EDGAR2Form 8-K - Current report
07/8/202313:00GLOBEPassage Bio Announces Promising Interim Clinical Data from..
01/8/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202313:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
31/7/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202323:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/7/202313:00GLOBEPassage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of..
29/7/202300:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202313:00EDGAR2Form 8-K - Current report
05/6/202313:00GLOBEPassage Bio to Present at Goldman Sachs 44th Annual Global..
11/5/202313:00GLOBEPassage Bio Reports First Quarter 2023 Financial Results and..
Apertura: 1,34 Min: 1,30 Max: 1,38
Chiusura: 1,34

La tua Cronologia

NASDAQ
PASG
Passage Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network